Oriola Corporation

💡 Want to succeed in the complex world of biosimilars – we're here to help! Whether it’s navigating different sources of data, creating standardised instructional videos for biological drug devices, or strategising on how to make more informed decisions, our team of experts can help you. Yesterday, they hosted a breakfast event with focus on biosimilars in Espoo. Some of the key highlights included: • Gaining a strategic edge with insights powered by advanced reference pricing and reimbursement data, supported by our Commercial Data Solutions • Exploring collaboration opportunities for producing instructional videos on biologic drug administration • Understanding patients’ views and experiences – lessons learned from Oriola’s survey of biologic medicine users. The presentation included survey results on treatment initiation and the importance of face-to-face instructions A warm thank you to all industry professionals who participated in the discussions! Did you miss the breakfast? 👉 Contact us Karla Blåfield 💎 Pekka Anttonen Paavo Raittinen Timo Purmonen Jussi Alinen Katja Lundell Varpu Vilkko or read more https://lnkd.in/eyQrrr3 #healthforlife #advisoryservices #biosimilars #pharmainsights

Pharmaceutical value chain in common exercise to strengthen preparedness 🔗🤝💊 Strengthening preparedness in pharmaceutical supply is a shared responsibility, and collaboration across the entire value chain is key. Oriola recently took part in an important exercise led by the Swedish Medical Products Agency, bringing together pharmacies, wholesalers, healthcare providers, and authorities to test how we can ensure access to medicines even in times of crisis.   “This exercise was a great example of how cooperation across the pharmaceutical supply chain can strengthen our collective preparedness. Concrete results, plans, and actions are essential to ensure that we are ready for any crisis that may arise in the future,” says Katarina Gabrielson, CEO of Oriola, who participated in the exercise.   We look forward to a follow-up later this year and to continuing the dialogue on opportunities and challenges in securing a resilient pharmaceutical supply. https://lnkd.in/d3YJnNVK #healthforlife #pharmaceuticalsupplychain #preparedness #resilience #läkemedelsverket

💡 New from our RWE team: Patients need better guidance to accept biosimilars – survey shows only 40% support pharmacy interchange ⚕️💉   With Finland’s new legislation enabling pharmacy interchange of biosimilars, understanding the needs and perspectives of patients using biological medicines has become critical. A comprehensive study conducted by our Real World Evidence (RWE) team reveals that while biosimilars offer significant cost-saving potential, only 40% of patients are open to substitution in pharmacies. Patients often lack knowledge about their treatment, highlighting the need for improvement.   The findings, detailed in two recently published articles, also emphasise that practical, face-to-face instruction – covering administration and side effects – is essential for treatment success, as well as shed light on the barriers to biosimilar adoption and the important role of education in addressing them.   “Building trust through education and collaboration between healthcare professionals is vital to drive the adoption of biosimilars. Patients but also pharmacists and doctors value reliable guidance to ensure successful transitions” says Tuire Prami, Oriola’s Senior RWE Scientist.   Read more about the study and insights into how patient guidance can support the transition to biosimilars https://lnkd.in/dwyc6Pbi   #biosimilars #patientguidance #RWE #healthforlife   Mari Pölkki Tuire Prami

“The supply chain is a crucial part of building customer experience” – Meet Tuomas Tiilikainen 🏭 🚛 This week, Tuomas joins Oriola as Chief Supply Chain Officer. With 15 years of experience across retail, fashion, grocery, and more, he brings valuable insights into digitalisation, sustainability, and customer experience—three key trends shaping the future of supply chain management. “The supply chain is a crucial part of both customer experience and business competitiveness. Digitalisation offers huge potential—creating opportunities to streamline processes, improve transparency, and make better use of data,” Tuomas says. “Sustainability is also becoming increasingly important, alongside the growing focus on customer experience.” In his first weeks, Tuomas will focus on understanding how our supply chain can drive efficiency, resilience, and customer value—while meeting the team and deepening his knowledge of our business and customers. We look forward to the journey ahead—welcome aboard, Tuomas!   #healthforlife #supplychain #digitaltransformation

💡 News from our RWE team; Increase in the occurrence of ADHD differs by age group and gender How has occurrence of ADHD evolved in recent years? A new study, initiated by and conducted in collaboration with Takeda, provides a detailed analysis of ADHD prevalence and incidence in Finland between 2015 and 2020. The study, based on nationwide register data, offers an in-depth look at ADHD diagnoses and medication use across all age groups, and presents the most comprehensive analysis of national register data in Finland. 💡 Key findings: - ADHD prevalence and incidence more than doubled during the study period. - Males had higher prevalence rates than females, particularly among children and adolescents. However, the relative increase was greater in females. - Approximately 80% of ADHD patients received medication annually, even as the prevalence rose. - A decrease in medication use was observed during the transition from adolescence to adulthood, raising questions about continuity of care. These findings contribute with valuable data to inform healthcare strategies and improve care for individuals with ADHD. Read the full article here: https://lnkd.in/d-_UHxRk #healthforlife #adhd #RWE #TakedaSuomi Elisa Westman Joel Jukka Tuire Prami Alvar Kallio Ilona Iso-Mustajärvi Paavo Raittinen Maarit Jaana Korhonen Anita Puustjärvi Sami Leppämäki

🌟 Greetings from the Oriola Clinical Research team at the 2025 European Clinical Research Conference (EUCROF25) in Copenhagen this week!🌟 We're attending and looking forward to meeting you to discuss how we can support your clinical research work moving forward - just reach out to Ulpu Andersson or Satu Nikander!   #EUCROF25 #clinicalresearch #collaboration #healthforlife

A big thank you to everyone who joined #NordicRWE2025! 💯 Oriola’s Advisory Services and RWE team had two insightful days at the University of Helsinki exploring the transformative potential of Real-World Data (RWD) and AI in medicine discovery and development. Finally, we had the pleasure of wrapping up the event with Paavo Raittinens engaging and thought-provoking session, “Can you outsource data interpretation to AI?” A special thanks to Mia Bengtström for organising this seminar. Looking forward to continuing the discovery and conversations on these fascinating topics - see you again next year! #healthforlife #rwe #data4ai Tuire Prami Paavo Raittinen Timo Purmonen Mari Pölkki Ilona Iso-Mustajärvi Varpu Vilkko Jussi Harmanen Jarno Ruotsalainen Ulpu Andersson Katja Lundell Marita Kalaoja

Hospital tenders of medicines in Finland – we can help you succeed! 🏥 💊   Did you know that competitive tendering for four out of five hospital districts in Finland will start in spring 2025?   “For pharmaceutical companies, competitive tendering offers a great opportunity to succeed in the Finnish healthcare market, and if you wish to participate, now’s the time to start preparing”, says Timo Purmonen, Head of Data Driven Business and Market Access. "We’re happy to guide you all the way through the tendering process".   In addition, our Translations team has several years of experience of translating the tender documents needed and is familiar with the process and the time constraints involved. Read more https://lnkd.in/d-kE3Wu8 or contact Timo Purmonen 📥

Faces of Oriola - Meet Joel Olsson Gulin, Sourcing Specialist 👋👥 Over his 11 years with us, Joel has made an inspiring journey—from starting as a warehouse worker to becoming a key player in our Assortment team. - Describe your role - what does it mean? As a Sourcing Specialist, I manage the revision window process—a challenging but exciting task where thousands of product changes must be coordinated smoothly and accurately. The main focus for the sourcing team is to develop Oriola's product portfolio to enable a wholesale offering of a wide range of health and wellbeing products to customers in Finland and Sweden, based on market and consumer needs - And what's your background? I’ve had a diverse career journey. After studying music in upper secondary school, I had various jobs, including construction work, sound engineering, and as a salesperson in an antique bookstore. Along the way, I discovered a deep interest in science, primarily mathematics and astronomy, which I studied further. This curiosity and passion for problem-solving have been invaluable in my current role. - What's the best part of your job? The best thing about my job is the opportunity to utilise my abilities as a problem solver—to explore, investigate, and find solutions for processes that need updating. I also value the fact that I’m always able to challenge and develop myself and, in turn, develop and refine the processes that define my job. And my colleagues - I could not have got where I am without them! - And finally, when you are not working, what do you like to do? Since I have a family including three beautiful daughters, most of my time is, of course, spent on normal family activities. When it comes to hobbies, mathematics and astronomy are at the top of my list and I have a soft spot for creating things. My current project is to build a chessboard along with all the pieces out of wood, as I’ve recently developed a great interest in the game itself. Curious to know more about Joel and his colleagues at Oriola? Find it here https://lnkd.in/dncfVxi6 #healthforlife #togetherforhealth #wholesale #assortment #sourcing Joel O. Gulin

Oriola acquires MedInfo ApS in Denmark to strengthen its Nordic footprint in medical information and patient support programmes 🤝   “With this acquisition, we will be able to offer a full-service portfolio in medical information and patient support programmes in all Nordic markets. Through our ongoing collaboration with MedInfo, we are already familiar with @MedInfo’s talented team and I am truly excited to welcome the team to join Oriola,” comments Katja Lundell, Executive Vice President, Advisory Services.     Medical information and patient support programmes are two of the local services that pharmaceutical companies request to be offered in local language, and which already are part of Oriola’s Advisory Services offering.  https://lnkd.in/d7fqJjs8 #healthcare #patientexperience #medicalinformation #businessgrowth